MedPath

An explorative study on cortical activation in normal hearing and in deaf adults, before and after cochlear implantation, measured with fMRI and NIRS.

Conditions
sensorineural hearing loss
severe hearing loss and deafness
10013995
10019243
Registration Number
NL-OMON32742
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1. Adults (18 years of age or older)
2. Right handed
3. Normal hearing group: having a pure-tone air conduction thresholds <= 15 dB HL
4. Unilaterally implanted pre-lingual deaf group: profound sensorineural hearing loss during the first 1.5 years of life
a. Implanted group with good results: consonant-vowel-consonant (CVC) score > 50% (open-set monosyllable lists according to the *Nederlandse Vereniging van Audiologie* (NVA)).
b. Implanted group with poor results: consonant-vowel-consonant (CVC) score < 50% (open-set, monosyllable lists according to NVA).
5. Prelingual deaf CI candidates: deaf or profound sensorineural hearing loss during the first 3 years of life, 90 dB < Pure tone average <120 dB

Exclusion Criteria

1.Pregnancy/breastfeeding
2.Subjects with intracorporeal metal components or electronic devices
3.Claustrophobic

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>A fMRI scan measured the cerebral blood flow (and hence the cortical activity)<br /><br>by differences in the regional Blood Oxygen Level Dependent (BOLD) response<br /><br>between activated and baseline (or control) condition.<br /><br><br /><br>To study the brain activity with NIRS, local changes in cortical oxy- and<br /><br>deoxyhemoglobin concentration are evaluated.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath